The forecasted market share for Poland's pharmaceutical exports from 2024 to 2028 indicates a slight downward trend. In 2023, the market share stood at 0.52. Over the next five years, there is a gradual yearly reduction from 0.51 in 2024 to 0.48 in 2028. The year-on-year percentage variation reveals minor decreases: a 1.96% drop from 2024 to 2025, 2% from 2025 to 2026, and a constant value from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over the period shows an average decline of 1.56% per year for the last five years.
Future trends to watch for in the pharmaceutical export market in Poland include potential impacts from regulatory changes within the European Union, shifts in global demand for pharmaceuticals, advancements in biotechnology, and the evolving landscape of healthcare post-pandemic. Monitoring these factors will be crucial for understanding future market dynamics.
